Helptext

Company Information

Company NameBiotech-IgG AB
Company Idea

"Biotech-IgG is a supplier of cutting-edge quality products for health care diagnostics and for research, routine and process scale applications for the LifeScience and food markets. Biotech-IgG group's vision is to become the leading Scandinavian distributor of immune diagnostics and life science products to the healthcare industry and that also offers a complete line of proprietary products for a well-defined customer group active in the production, development and analysis of proteins, especially antibodies."

Phone+46 46 12 37 40CEODario Kriz
E-mailinfo(snabel-a)biotech-igg(punkt)comChairm. of the BoardMargareta Krook
Homepagehttp://www.biotech-igg.com 

Instrument Information

Full NameBiotech-IgG BShort NameBIGG B
No of shares218,683,220Par Value0.05 SEK
TypeShareISIN codeSE0002837955
InfoObs-listad den 22 maj 2017, se pressmeddelande från AktieTorget samma dag

Price Information

+/-(0.005)
%-5.00
Latest0.095
High0.10
Low0.092
Volume184,941
Turnover (SEK)17,507
Market Cap (MSEK) 20.8
On surveillance listOB

Orders

VolumeBidAskVolume
31,0000.0950.10112,066
97,2560.0930.10880,553
5,0000.0920.1174,532
70,0000.0910.12545,685
250,0000.090.123160,000
50,0000.0850.128310,534
50,0000.0830.1525,000
100,0000.0820.1871,500
100,0000.0810.2020,000
20,0000.080.25349,999
  0.28200,000
  0.30115,000
  0.36400,000
  0.431,250,000

Deals

TimeBuyerSellerPriceVolume
2:59 PMNRDAVA0.09519,000
2:25 PMAVAAVA0.101,000
12:55 PMNONENS0.0934,249
11:09 AMAVAAVA0.1045,000
9:05 AMAVANRD0.09265,000
9:05 AMAVANRD0.09225,000
9:04 AMMLINRD0.09320,382
9:00 AMSWBSHB0.10310
9:00 AMSWBSHB0.105,000

Scheduled Reports

DateReport
2017-08-25Halvårsrapport
2017-10-27Delårsrapport tre
2018-02-28Bokslutskommuniké för 2017

Latest Movies

DateDescription




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se